Carol Paronis

Affiliations: 
McLean Hospital, Harvard Medical School, Belmont, MA, United States 
Google:
"Carol Paronis"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wang M, Irvin TC, Herdman CA, et al. (2020) The Intriguing Effects of Substituents in the -Phenethyl Moiety of Norhydromorphone: A Bifunctional Opioid from a Set of "Tail Wags Dog" Experiments. Molecules (Basel, Switzerland). 25
Paronis CA, Chopda GR, Vemuri K, et al. (2018) Long-lasting in vivo effects of the cannabinoid CB1 antagonist AM6538. The Journal of Pharmacology and Experimental Therapeutics
Nikas SP, Sharma R, Paronis CA, et al. (2015) Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols. Journal of Medicinal Chemistry. 58: 665-81
Sharma R, Nikas SP, Paronis CA, et al. (2013) Controlled-deactivation cannabinergic ligands. Journal of Medicinal Chemistry. 56: 10142-57
Chopda GR, Vemuri VK, Sharma R, et al. (2013) Diuretic effects of cannabinoid agonists in mice. European Journal of Pharmacology. 721: 64-9
Thakur GA, Bajaj S, Paronis C, et al. (2013) Novel adamantyl cannabinoids as CB1 receptor probes. Journal of Medicinal Chemistry. 56: 3904-21
Paronis CA, Thakur GA, Bajaj S, et al. (2013) Diuretic effects of cannabinoids. The Journal of Pharmacology and Experimental Therapeutics. 344: 8-14
Paronis CA, Nikas SP, Shukla VG, et al. (2012) Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Behavioural Pharmacology. 23: 802-5
Bergman J, Delatte MS, Paronis CA, et al. (2008) Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiology & Behavior. 93: 666-70
Desai RI, Neumeyer JL, Paronis CA, et al. (2007) Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys. European Journal of Pharmacology. 558: 98-106
See more...